(IPAF), undifferentiated connective tissue disease, ankylosing spondylitis, antineutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus (SLE), or unclassifiable ILD. There was a need to limit the guideline scope, so the five diseases in which ILD occurs most frequently were prioritized. IPAF was not included because it is a research classification rather than a clinical diagnosis. Also, this guideline was not developed to guide evaluation for SARDs in patients with newly diagnosed ILD without a prior recognized SARD. Interventions. The panel considered the following diagnostic and screening interventions: history and physical examination alone (including assessment of dyspnea, functional class,  Diffuse cutaneous subtype, male sex, African American race â€¢ High-titer rheumatoid factor, high-titer anti-CCP cough, and fatigue on history; tachypnea, cyanosis, and percussion for altered lung resonance and auscultation for crackles on physical examination),